Dusseldorf - Delayed Quote EUR
Fate Therapeutics Inc (F6T.DU)
0.8592
+0.0034
+(0.40%)
As of 4:31:30 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-122,874
-122,874
-132,263
-248,208
-162,870
Investing Cash Flow
12,218
12,218
112,665
166,751
-324,023
Financing Cash Flow
99,892
99,892
85
9,207
453,129
End Cash Position
46,283
46,283
57,047
76,560
148,810
Interest Paid Supplemental Data
--
--
--
--
0
Capital Expenditure
-730
-730
-6,153
-35,566
-50,704
Issuance of Capital Stock
74,531
74,531
0
0
411,735
Repayment of Debt
--
--
--
--
0
Free Cash Flow
-123,604
-123,604
-138,416
-283,774
-213,574
12/31/2021 - 12/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1CVAC.MI CureVac N.V.
3.0600
+0.13%
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
P0F.F Egetis Therapeutics AB (publ)
0.2975
-2.94%
688068.SS Beijing Hotgen Biotech Co., Ltd.
98.98
-2.65%
1TB0.SG Orphazyme AS
137.50
+0.36%
688428.SS InnoCare Pharma Limited
20.62
+3.57%
328.SG MeiraGTx Holdings PLC
4.0600
-0.49%
BSFAF BSF Enterprise Plc
0.0350
+75.00%
CSJA.F CSL Limited
66.50
-1.48%
22UA.MU BioNTech SE
82.45
-0.30%